|
|
| (108 dazwischenliegende Versionen von einem Benutzer werden nicht angezeigt) |
| Zeile 1: |
Zeile 1: |
| | __NOTOC__ | | __NOTOC__ |
| | *'''[[Further reading]]''' | | *'''[[Further reading]]''' |
| | + | |
| | | | |
| | *'''[[Unproven ideas]]''' | | *'''[[Unproven ideas]]''' |
| | + | |
| | *'''[[Reviews on covid19 disease]]''' | | *'''[[Reviews on covid19 disease]]''' |
| − | {{tp|p=32314790|t=ä. What s New With the Old Coronaviruses?|pdf=|usr=}}
| + | *'''[[Clinical guidelines and advice]]''' |
| − | {{tp|p=32309679|t=ä. COVID-19 Clinical Trials: A Primer for the Cardiovascular and Cardio-Oncology Communities |pdf=|usr=}}
| + | |
| − | {{tp|p=32313885|t=ä. COVID-19 Clinical Trials: A Primer for the Cardiovascular and Cardio-Oncology Communities |pdf=|usr=}}
| + | |
| − | {{tp|p=C7151394|t=ä. COVID-19 for the Cardiologist: A Current Review of the Virology, Clinical Epidemiology, Cardiac and Other Clinical Manifestations and Potential Therapeutic Strategies |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| − | *'''[[Clinical guidelines and advice]]'''
| |
| − | {{tp|p=32360205|t=ä. What do surgeons need to know about the digestive disorders and paraclinical abnormalities induced by COVID-19?|pdf=|usr=}}
| |
| | | | |
| | + | *'''[[Respiration mgmt]]''' |
| | | | |
| − | ----
| + | *'''[[Diagnosis (Laboratory)]]''' |
| | | | |
| | | | |
| − | *'''[[Structure of covid19]]''' | + | *'''[[Diagnosis (Lung CT, Sonography)]]''' |
| − | {{tp|p=32320687|t=ä. Phylogenetic Analysis and Structural Modeling of SARS-CoV-2 Spike Protein Reveals an Evolutionary Distinct and Proteolytically Sensitive Activation Loop |pdf=|usr=}}
| + | |
| − | {{tp|p=32200634|t=ä. Protein Structure and Sequence Reanalysis of 2019-nCoV Genome Refutes Snakes as Its Intermediate Host and the Unique Similarity between Its Spike Protein Insertions and HIV-1 |pdf=|usr=}}
| + | |
| − | {{tp|p=32321524|t=2020. Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant |pdf=|usr=}}
| + | |
| − | {{tp|p=32357959|t=2020. An 81 nucleotide deletion in SARS-CoV-2 ORF7a identified from sentinel surveillance in Arizona (Jan-Mar 2020) |pdf=|usr=}}
| + | |
| | | | |
| − | *'''[[Target binding and uptake]]''' | + | *'''[[Diagnosis (other modalities)]]''' |
| − | {{tp|p=31996437|t=2020. Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus |pdf=|usr=}}
| + | |
| − | {{ttp|p=31826992|t=2020. Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry |pdf=|usr=}}''antibodies target one serotype of viruses but only subneutralize another, leading to antibody-dependend enhancement of the latter viruses.''
| + | |
| | | | |
| − | *'''[[Cytopathic effects]]'''
| |
| | | | |
| − | *'''[[Secretion and shedding]]'''
| |
| | | | |
| − | *'''[[Innate sensing]]'''
| |
| | | | |
| − | *'''[[Immunology]]''' | + | *'''[[Structure of covid19]]''' |
| − | {{tp|p=32292901|t=2020. Pathogenic priming likely contributes to serious and critical illness and mortality in COVID-19 via autoimmunity |pdf=|usr=}}
| + | |
| − | {{tp|p=32303592|t=2020. Human leukocyte antigen susceptibility map for SARS-CoV-2 |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| − | *'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]''' | + | *'''[[Target binding and uptake]]''' |
| | + | *'''[[Cytopathic effects]]''' |
| | + | *'''[[Secretion and shedding]]''' |
| | | | |
| − | ----
| |
| | | | |
| | | | |
| | + | *'''[[Innate sensing]]''' |
| | | | |
| | + | *'''[[Immunology]]''' |
| | | | |
| − | *'''[[Early symptoms]]''' | + | *'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]''' |
| | | | |
| − | *'''[[Systemic disease, any manifestations]]'''
| |
| | | | |
| − | *'''[[Co-Infection]]'''
| |
| − | {{tp|p=32307254|t=ä. Invasive fungal diseases during COVID-19: We should be prepared |pdf=|usr=}}
| |
| − | {{tp|p=32297939|t=ä. SARS-CoV-2 and Legionella Co-infection in a Person Returning from a Nile Cruise |pdf=|usr=}}
| |
| | | | |
| | + | *'''[[Pathobiology]]''' |
| | | | |
| | | | |
| − | *'''[[ARDS]]''' | + | *'''[[Disease Models]]''' |
| | | | |
| − | *'''[[Pulmonary embolism, coagulation]]'''
| |
| − | {{tp|p=32311448|t=ä. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up |pdf=|usr=}}
| |
| − | {{tp|p=32212240|t=2020. Disseminated intravascular coagulation in patients with 2019?nCoV pneumonia |pdf=|usr=}}
| |
| − | {{tp|p=32073213|t=2020. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia |pdf=|usr=}}
| |
| − | {{tp|p=32372336|t=ä. Pulmonary intravascular coagulation in COVID-19: possible pathogenesis and recommendations on anticoagulant/thrombolytic therapy |pdf=|usr=}}
| |
| − | {{tp|p=32367471|t=ä. Venous thromboembolism and heparin use in COVID-19 patients: juggling between pragmatic choices, suggestions of medical societies |pdf=|usr=}}
| |
| − | {{tp|p=32338320|t=ä. Covid-19 treatment update: follow the scientific evidence |pdf=|usr=}}
| |
| − | {{tp|p=32246317|t=ä. Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2 |pdf=|usr=}}
| |
| − | {{tp|p=32306290|t=ä. Venous thrombosis and arteriosclerosis obliterans of lower extremities in a very severe patient with 2019 novel coronavirus disease: a case report |pdf=|usr=}}
| |
| − | {{tp|p=32330267|t=ä. Pulmonary embolism in returning traveler with COVID-19 pneumonia |pdf=|usr=}}
| |
| − | {{tp|p=32360371|t=ä. Thromboembolic events in patients with SARS-CoV-2 |pdf=|usr=}}
| |
| − | {{tp|p=32360679|t=ä. Acute limb ischemia in patients with COVID-19 pneumonia |pdf=|usr=}}
| |
| − | {{tp|p=32305586|t=ä. Upsurge of deep venous thrombosis in patients affected by COVID-19: Preliminary data and possible explanations |pdf=|usr=}}
| |
| − | {{tp|p=32360372|t=ä. An increased severity of peripheral arterial disease in the covid-19 era |pdf=|usr=}}
| |
| − | {{tp|p=32361070|t=2020. Cardiovascular examination should also include peripheral arterial evaluation for COVID-19 patients |pdf=|usr=}}
| |
| | | | |
| − | *'''[[Hematology]]''' | + | *'''[[Similar diseases and pathomechanisms]]''' |
| | | | |
| − | *'''[[Microvascular]]'''
| |
| | | | |
| − | *'''[[Heart]]'''
| |
| − | {{tp|p=C7151324|t=ä. The Heart in COVID19: Primary Target or Secondary Bystander?|pdf=|usr=}}
| |
| | | | |
| | | | |
| | + | *'''[[Early symptoms]]''' |
| | | | |
| − | *'''[[Neurology, ophthalmology, orl]]''' | + | *'''[[Systemic disease, any manifestations]]''' |
| | | | |
| | + | *'''[[Co-Infection]]''' |
| | | | |
| − | *'''[[Dermatology]]'''
| |
| − | {{tp|p=32352022|t=2020. Urticarial exanthem as early diagnostic clue for COVID-19 infection |pdf=|usr=}}
| |
| − | {{tp|p=32346588|t=ä. Dermatologic findings in two patients with COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32313826|t=ä. Morbilliform exanthem associated with COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32363225|t=ä. Coronavirus (COVID-19) infection-induced chilblains: A case report with histopathologic findings |pdf=|usr=}}
| |
| | | | |
| | + | *'''[[Pulmonary embolism, coagulation]]''' |
| | | | |
| | | | |
| | | | |
| − | *'''[[Gastroenterology, hepatology]]'''
| |
| − | {{tp|p=32363540|t=ä. Bowel Necrosis in the Setting of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32298767|t=ä. COVID-19: Abnormal liver function tests |pdf=|usr=}}
| |
| − | {{tp|p=32249184|t=ä. Can COVID-19 present unusual GI symptoms?|pdf=|usr=}}
| |
| | | | |
| − | *'''[[Kidney, urology]]'''
| |
| | | | |
| − | ----
| + | *'''[[Hematology]]''' |
| | | | |
| | | | |
| − | *'''[[Pathobiology]]'''
| |
| | | | |
| − | *'''[[Disease Models]]''' | + | *'''[[Heart]]''' |
| | | | |
| − | *'''[[Similar diseases and pathomechanisms]]'''
| |
| − | {{tp|p=32370951|t=ä. Missed or Delayed Diagnosis of Kawasaki Disease During the 2019 Novel Coronavirus Disease (COVID-19) Pandemic |pdf=|usr=}}
| |
| | | | |
| − | ----
| |
| | | | |
| | + | *'''[[Neurology, ophthalmology, orl]]''' |
| | | | |
| − | *'''[[Diagnosis (Laboratory)]]'''
| |
| − | {{tp|p=32031264|t=2020. Evolving status of the 2019 novel coronavirus infection: Proposal of conventional serologic assays for disease diagnosis and infection monitoring |pdf=|usr=}}
| |
| − | {{ttp|p=31944312|t=2020. Recent advances in the detection of respiratory virus infection in humans |pdf=|usr=}}
| |
| − | {{tp|p=32276051|t=ä. Development of Reverse Transcription Loop-Mediated Isothermal Amplification Assays Targeting SARS-CoV-2 |pdf=|usr=}}
| |
| − | {{tp|p=32292623|t=2020. Recent advances and perspectives of nucleic acid detection for coronavirus |pdf=|usr=}}
| |
| | | | |
| | | | |
| | + | *'''[[Dermatology]]''' |
| | | | |
| − | *'''[[Diagnosis (Lung CT, Sonography)]]'''
| |
| − | {{tp|p=32279977|t=ä. What We Know So Far (As of March 26, 2020) About COVID-19 ? An MRT Point of View |pdf=|usr=}}
| |
| − | {{tp|p=32328927|t=2020. (J Med Ultrasound) COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32292624|t=2020. Quantitative computed tomography analysis for stratifying the severity of Coronavirus Disease 2019 |pdf=|usr=}}
| |
| − | {{tp|p=32252784|t=2020. CT imaging changes of corona virus disease 2019(COVID-19): a multi-center study in Southwest China |pdf=|usr=}}
| |
| − | {{ttp|p=C7159975|t=ä. Thoracic ultrasound and SARS-COVID-19: a pictorial essay |pdf=|usr=}}
| |
| | | | |
| | | | |
| − | *'''[[Diagnosis (other modalities)]]''' | + | *'''[[Gastroenterology, hepatology]]''' |
| − | {{tp|p=32344326|t=2020. COVID-19 and malaria: A symptom screening challenge for malaria endemic countries |pdf=|usr=}}
| + | |
| | | | |
| | + | *'''[[Kidney, urology]]''' |
| | | | |
| − | *'''[[Respiration mgmt]]''' | + | *'''[[The morbid survivor]]''' |
| − | {{tp|p=32340627|t=2020. Recommendations from the CSO-HNS taskforce on performance of tracheotomy during the COVID-19 pandemic |pdf=|usr=}}
| + | |
| − | | + | |
| | | | |
| | *'''[[Risk and special populations]]''' | | *'''[[Risk and special populations]]''' |
| Zeile 142: |
Zeile 89: |
| | | | |
| | | | |
| | + | *'''[[Case reports]]''' |
| | | | |
| | | | |
| − | *'''[[The morbid survivor]]'''
| |
| | | | |
| | | | |
| | | | |
| | | | |
| − | *'''[[Case reports]]'''
| |
| − | {{tp|p=32168162|t=ä. A Diabetic Patient With 2019-nCoV (COVID-19) Infection Who Recovered and Was Discharged From Hospital |pdf=|usr=}}
| |
| − | {{tp|p=32147577|t=2020. Treatment and Outcome of a Patient With Lung Cancer Infected With Severe Acute Respiratory Syndrome Coronavirus-2 |pdf=|usr=}}
| |
| − | {{tp|p=32330274|t=ä. COVID-19 with spontaneous pneumothorax,pneumomediastinum and subcutaneous emphysema |pdf=|usr=}}
| |
| | | | |
| | *'''[[Case series]]''' | | *'''[[Case series]]''' |
| − | {{tp|p=32360416|t=ä. The curious case of coronavirus disease 2019 (COVID-19) in children |pdf=|usr=}}
| + | |
| | | | |
| | *'''[[Registries]]''' | | *'''[[Registries]]''' |
| − | {{tp|p=32305438|t=ä. The AAD COVID-19 Registry: Crowdsourcing Dermatology in the Age of COVID-19 |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − | ----
| |
| | | | |
| | | | |
| | *'''[[Trials]]''' | | *'''[[Trials]]''' |
| − | {{tp|p=32290293|t=2020. A Review of SARS-CoV-2 and the Ongoing Clinical Trials |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | *'''[[Candidate Compounds Covid19]]''' | | *'''[[Candidate Compounds Covid19]]''' |
| − | {{tp|p=32353597|t=ä. SARS-COV2 INFECTION AND LUNG CANCER PATIENTS: the potential role of IL17 target therapy |pdf=|usr=}}
| |
| − | {{tp|p=32281481|t=2020. Challenges and cares to promote rational use of chloroquine and hydroxychloroquine in the management of coronavirus disease 2019 (COVID-19) pandemic: a timely review |pdf=|usr=}}
| |
| − | {{tp|p=32370758|t=2020. SARS-CoV-2 RNA polymerase as target for antiviral therapy |pdf=|usr=}}
| |
| − | {{tp|p=C7154570|t=2020. Anti-IL6R role in treatment of COVID-19-related ARDS |pdf=|usr=}}
| |
| − | {{tp|p=32290839|t=2020. Why tocilizumab could be an effective treatment for severe COVID-19?|pdf=|usr=}}
| |
| − | {{tp|p=32313848|t=ä. Precision medicine in COVID-19: IL-1 beta a potential target |pdf=|usr=}}
| |
| | | | |
| | | | |
| | + | *'''[[Other routes of infection]]''' |
| | | | |
| − | ----
| |
| | | | |
| − | *'''[[Remission, recurrence and persistence]]''' | + | *'''[[Biophysics of aerosols]]''' |
| − | {{tp|p=32303482|t=ä. Re-emergence of SARS-CoV2 in a discharged COVID-19 case |pdf=|usr=}}
| + | |
| − | {{tp|p=32299784|t=ä. How do we decide to de-isolate COVID-19 patients?|pdf=|usr=}}
| + | |
| | | | |
| − | *'''[[Other routes of infection]]'''
| |
| − | {{tp|p=32276848|t=ä. Prolonged viral shedding in feces of pediatric patients with coronavirus disease 2019 |pdf=|usr=}}
| |
| − | {{tp|p=32224116|t=ä. Do children need a longer time to shed SARS-CoV-2 in stool than adults?|pdf=|usr=}}
| |
| | | | |
| − |
| |
| − | *'''[[Biophysics of aerosols]]'''
| |
| − | {{tp|p=32340347|t=2020. Airborne Transmission Route of COVID-19: Why 2 Meters/6 Feet of Inter-Personal Distance Could Not Be Enough |pdf=|usr=}}
| |
| − | {{tp|p=32360356|t=ä. Putting some context to the aerosolization debate around SARS-CoV-2 |pdf=|usr=}}
| |
| | | | |
| | | | |
| | *'''[[Passive protective equipment]]''' | | *'''[[Passive protective equipment]]''' |
| | + | |
| | | | |
| | | | |
| | *'''[[Running your hospital]]''' | | *'''[[Running your hospital]]''' |
| − | {{tp|p=32289516|t=ä. Coronavirus Disease 2019 in the Perioperative Period of Lung Resection: A Brief Report From a Single Thoracic Surgery Department in Wuhan, People?s Republic of China |pdf=|usr=}}
| |
| − | {{tp|p=32345905|t=2020. Surgical Stabilization of Rib Fractures during the COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32340864|t=ä. COVID-19: What Should Interventional Radiologists Know and What Can They Do?|pdf=|usr=}}
| |
| − | {{tp|p=32331919|t=ä. (Interv.Rad.) Preparing IR for COVID-19: The Singapore Experience |pdf=|usr=}}
| |
| − | {{tp|p=32360375|t=ä. Forgetting ?routine? DVT and stroke during COVID-19 is a parallel pandemic that will be costly if ignored |pdf=|usr=}}
| |
| − | {{tp|p=32361072|t=ä. Emerging Practice Patterns in Vascular Surgery During the COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32361069|t=ä. Development of a Surgical Workforce Access Team (SWAT) in the Battle Against COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32360683|t=ä. COVID-19 financial resources for physicians |pdf=|usr=}}
| |
| − | {{tp|p=32360682|t=2020. Cardiovascular disease and surgery amid COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32360680|t=ä. Pattern of Vascular Disease in Lombardia (Italy) during the first month of the COVID-19 outbreak |pdf=|usr=}}
| |
| − | {{tp|p=32360677|t=ä. The Impact of COVID-19 on Vascular Training |pdf=|usr=}}
| |
| − | {{tp|p=32344111|t=ä. Vascular surgery in the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32335307|t=ä. Early experience in Paris with the impact of the COVID-19 pandemic on vascular surgery |pdf=|usr=}}
| |
| − | {{tp|p=32334050|t=ä. The Vascular Surgery Covid-19 Collaborative (VASCC) |pdf=|usr=}}
| |
| − | {{tp|p=32305387|t=ä. Early Experience in the COVID-19 pandemic from a Vascular Surgery Unit in a Singapore Tertiary Hospital |pdf=|usr=}}
| |
| − | {{tp|p=32305385|t=ä. Perspectives on vascular surgical practice change due to COVID-19 at a nonacademic tertiary care center |pdf=|usr=}}
| |
| − | {{tp|p=32305382|t=ä. Vascular surgery department adjustments in the era of the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32305384|t=ä. Creation of a vascular surgical Hub responding to the COVID-19 emergency: the italian USL Toscana Centro model |pdf=|usr=}}
| |
| − | {{tp|p=32289438|t=ä. Doing the right thing for the right reason when treating ruptured abdominal aortic aneurysms in the COVID-19 era |pdf=|usr=}}
| |
| − | {{tp|p=32289437|t=ä. Delivering high-quality vascular care by telehealth during the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32247030|t=ä. A military perspective on the vascular surgeon s response to the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32247029|t=ä. The global impact of COVID-19 on vascular surgical services |pdf=|usr=}}
| |
| − | {{tp|p=32322766|t=ä. Achieving a Popliteal Venous Access for RRT in Critically Ill COVID-19 Patient in Prone position |pdf=|usr=}}
| |
| − | {{tp|p=32305585|t=ä. Practical diagnosis and treatment of suspected venous thromboembolism during COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32335008|t=ä. Urgent digestive surgery, a collateral victim of the Covid-19 crisis?|pdf=|usr=}}
| |
| − | {{tp|p=32362368|t=ä. Antibiotics alone as an alternative to appendectomy for uncomplicated acute appendicitis in adults: changes in treatment modalities related to the COVID-19 health crisis |pdf=|usr=}}
| |
| − | {{tp|p=32363343|t=2020. Infection prevention and control (IPC) for novel coronavirus (COVID-19) |pdf=|usr=}}
| |
| − | {{tp|p=32328590|t=ä. Cardio-oncology Care in the Time of COVID-19 and the Role of Telehealth |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − | ----
| |
| | | | |
| | | | |
| | *'''[[Mental aspects of health professionals]]''' | | *'''[[Mental aspects of health professionals]]''' |
| − |
| |
| | | | |
| | *'''[[Socio-psychiatric aspects of the status hygienicus]]''' | | *'''[[Socio-psychiatric aspects of the status hygienicus]]''' |
| Zeile 240: |
Zeile 131: |
| | | | |
| | *'''[[Avoiding clinical medicine in other diseases]]''' | | *'''[[Avoiding clinical medicine in other diseases]]''' |
| − | {{tp|p=32283124|t=ä. Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States during COVID-19 Pandemic |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| | *'''[[Occupational medicine, workplace security and status hygienicus]]''' | | *'''[[Occupational medicine, workplace security and status hygienicus]]''' |
| | + | |
| | + | |
| | *'''[[Economic aspects of the status hygienicus]]''' | | *'''[[Economic aspects of the status hygienicus]]''' |
| − | {{tp|p=32325710|t=2020. The COVID-19 Outbreak and Affected Countries Stock Markets Response |pdf=|usr=}}
| |
| − | {{tp|p=32305533|t=ä. The Socio-Economic Implications of the Coronavirus and COVID-19 Pandemic: A Review |pdf=|usr=}}
| |
| − | {{tp|p=32292707|t=ä. Death and contagious infectious diseases: Impact of the COVID-19 virus on stock market returns |pdf=|usr=}}
| |
| − | {{tp|p=32048740|t=2020. Economic impacts of Wuhan 2019?nCoV on China and the world |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | | | |
| Zeile 257: |
Zeile 145: |
| | | | |
| | *'''[[Host, vector, one health, atmospheric aspects]]''' | | *'''[[Host, vector, one health, atmospheric aspects]]''' |
| − | {{tp|p=31967321|t=2020. Cross?species transmission of the newly identified coronavirus 2019?nCoV |pdf=|usr=}}
| |
| − | {{tp|p=32346658|t=ä. SARS-CoV-2 and Bats: From Flight to Fighting COVID-19 |pdf=|usr=}}
| |
| | | | |
| | *'''[[Origin of Covid19]]''' | | *'''[[Origin of Covid19]]''' |
| − | {{tp|p=32277970|t=ä. Strategies to trace back the origin of COVID-19 |pdf=|usr=}}
| |
| | | | |
| | + | *'''[[Epidemiology]]''' |
| | | | |
| | | | |
| − | *'''[[Epidemiology]]'''
| |
| − | {{tp|p=32337154|t=2020. Editorial The Coronavirus Disease COVID-19 and implications for transport and health |pdf=|usr=}}
| |
| − | {{tp|p=32227186|t=ä. High population densities catalyze the spread of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32211801|t=ä. Health measures to travelers and cruise ships in response to COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32211799|t=ä. Routes for COVID-19 importation in Brazil |pdf=|usr=}}
| |
| − | {{tp|p=32181488|t=ä. The positive impact of lockdown in Wuhan on containing the COVID-19 outbreak in China |pdf=|usr=}}
| |
| − | {{tp|p=32181483|t=ä. Correlation between travellers departing from Wuhan before the Spring Festival and subsequent spread of COVID-19 to all provinces in China |pdf=|usr=}}
| |
| − | {{tp|p=32167146|t=ä. Interrupting transmission of COVID-19: lessons from containment efforts in Singapore |pdf=|usr=}}
| |
| − | {{tp|p=32080723|t=2020. Quantifying the association between domestic travel and the exportation of novel coronavirus (2019-nCoV) cases from Wuhan, China in 2020: a correlational analysis |pdf=|usr=}}
| |
| − | {{tp|p=32052846|t=2020. The reproductive number of COVID-19 is higher compared to SARS coronavirus |pdf=|usr=}}
| |
| − | {{ttp|p=32052841|t=2020. Isolation, quarantine, social distancing and community containment: pivotal role for old-style public health measures in the novel coronavirus (2019-nCoV) outbreak |pdf=|usr=}}
| |
| − | {{tp|p=32010938|t=2020. Travellers give wings to novel coronavirus (2019-nCoV) |pdf=|usr=}}
| |
| − | {{tp|p=31943059|t=2020. Pneumonia of unknown aetiology in Wuhan, China: potential for international spread via commercial air travel |pdf=|usr=}}
| |
| − | {{tp|p=32163140|t=ä. Serial interval in determining the estimation of reproduction number of the novel coronavirus disease (COVID-19) during the early outbreak |pdf=|usr=}}
| |
| − | {{tp|p=32109274|t=ä. Saudi Arabia`s measures to curb the COVID-19 outbreak: temporary suspension of the Umrah pilgrimage |pdf=|usr=}}
| |
| − | {{tp|p=32109273|t=ä. COVID-19 outbreak on the Diamond Princess cruise ship: estimating the epidemic potential and effectiveness of public health countermeasures |pdf=|usr=}}
| |
| − | {{tp|p=32104884|t=ä. Nepal?s First Case of COVID-19 and public health response |pdf=|usr=}}
| |
| − | {{tp|p=32268358|t=ä. Spread of Novel Coronavirus by Returning Pilgrims from Iran to Pakistan |pdf=|usr=}}
| |
| − | {{tp|p=32324879|t=ä. Non-pharmaceutical interventions used for COVID-19 had a major impact on reducing influenza in China in 2020 |pdf=|usr=}}
| |
| − | {{ttp|p=32339236|t=ä. COVID-19 pandemic: It is time to temporarily close places of worship and to suspend religious gatherings |pdf=|usr=}}
| |
| − | {{tp|p=32307549|t=ä. A Single Mass Gathering Resulted in Massive Transmission of COVID-19 Infections in Malaysia with Further International Spread |pdf=|usr=}}
| |
| − | {{tp|p=32307526|t=ä. Community Universal Face Mask Use during the COVID 19 pandemic?from households to travelers and public spaces |pdf=|usr=}}
| |
| − | {{tp|p=32307521|t=ä. Containing COVID-19 in rural and remote areas: experiences from China |pdf=|usr=}}
| |
| − | {{tp|p=32297942|t=ä. Reducing onward spread of COVID-19 from imported cases: quarantine and ?stay at home? measures for travellers and returning residents to Singapore |pdf=|usr=}}
| |
| − | {{tp|p=32297940|t=ä. High prevalence of SARS-CoV-2 infection in repatriation flights to Greece from three European countries |pdf=|usr=}}
| |
| − | {{tp|p=32333243|t=ä. Slum Health: Arresting COVID-19 and Improving Well-Being in Urban Informal Settlements |pdf=|usr=}}
| |
| − | {{tp|p=32328866|t=ä. Disability, Urban Health Equity, and the Coronavirus Pandemic: Promoting Cities for All |pdf=|usr=}}
| |
| − | {{tp|p=32340900|t=ä. Risks of viral contamination in healthcare professionals during laparoscopy in the Covid-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32363224|t=ä. Use of a novel adhesive suture retention wound closure device to prevent patient follow-up visits during COVID-19 pandemic |pdf=|usr=}}
| |
| | | | |
| | | | |
| − | *'''[[Failure of politics and public health guidance]]''' | + | |
| | + | *'''[[Remission, recurrence and persistence]]''' |
| | + | |
| | + | |
| | | | |
| | *'''[[Failure of executive measures]]''' | | *'''[[Failure of executive measures]]''' |
| | ---- | | ---- |
| | + | *'''[[Failure of politics and public health guidance]]''' |
| | | | |
| | | | |
| | *'''[[Political abuse of Covid19]]''' | | *'''[[Political abuse of Covid19]]''' |
| − | {{tp|p=32309854|t=ä. World leaders? usage of Twitter in response to the COVID-19 pandemic: a content analysis |pdf=|usr=}}
| |
| | | | |
| | | | |
| | | | |
| | *'''[[Lost people]]''' | | *'''[[Lost people]]''' |
| − | {{tp|p=32142979|t=2020. Li Wenliang, a face to the frontline healthcare worker The first doctor to notify the emergence of the SARS-CoV-2, (COVID-19), outbreak |pdf=|usr=}}
| |
| − | {{tp|p=32271208|t=ä. Survey of COVID-19 Disease Among Orthopaedic Surgeons in Wuhan, People?s Republic of China |pdf=|usr=}}
| |
| − | {{tp|p=32277966|t=ä. Characteristics of deaths amongst health workers in China during the outbreak of COVID-19 infection |pdf=|usr=}}
| |
| − | {{tp|p=32292846|t=2020. Chinese Health Care Workers and COVID-19: For Whom the Bell Tolls |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| | | | |
| | *'''[[Lost civilization]]''' | | *'''[[Lost civilization]]''' |
| | + | |
| | ---- | | ---- |
| | | | |
| | | | |
| | *'''[[History of covid19 exploration]]''' | | *'''[[History of covid19 exploration]]''' |
| − | {{tp|p=32120913|t=2020. Epidemiological Identification of A Novel Pathogen in Real Time: Analysis of the Atypical Pneumonia Outbreak in Wuhan, China, 2019?2020 |pdf=|usr=}}
| |
| − | {{tp|p=32001309|t=2020. Emergence of a novel coronavirus causing respiratory illness from Wuhan, China |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| | *'''[[misc.]]''' | | *'''[[misc.]]''' |
| − | {{tp|p=32333979|t=ä. Lessons already learnt from the Covid-19 pandemic |pdf=|usr=}}
| + | |
| − | {{tp|p=32305592|t=ä. Alert to Potential Contagiousness: A Case of Lung Cancer with Asymptomatic SARS-CoV-2 Infection |pdf=|usr=}}
| + | |
| | | | |
| | *'''[[Research tools]]''' | | *'''[[Research tools]]''' |
| | + | |
| | + | |
| | + | |
| | + | |
| | + | {{tp|p=27490990|t=2017. AVCpred: an integrated web server for prediction and design of antiviral compounds |pdf=|usr=}} |
| | + | {{tp|p=25040500|t=2014. Engineering large viral DNA genomes using the CRISPR?Cas9 system |pdf=|usr=}} |
| | + | |
| | + | |
| | + | *'''[[PrePrint scene]]''' |
| | + | |
| | | | |
| | *'''[[from the ads]]''' | | *'''[[from the ads]]''' |
| − | *[lifechemicals.com antiviral candidate drugs]
| |
| − | *[biomol.com assays cytokines general spectrum]
| |
| − | *[labospace.com custom single probe assay 400 possible cytokines and so on]
| |
| − | *[codexdna.com dna synthesis]
| |
| − | *
| |
| | | | |
| | *'''[[Current state of coviki.org]]''' | | *'''[[Current state of coviki.org]]''' |
| | + | *'''[[on-topic personal thoughts]]''' |
